4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307229
See Remarks sold 5,000 shares at $79.53 ($397,632)
- See Remarks acquired 5,000 shares (option exercise)
- See Remarks acquired 356 shares (grant or award)
- See Remarks gave up 110 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-12-01 | Option exercise 10b5-1 | +5,000 | $13.56 | $67,800 | 15,277 | D: show line 1 in the form |
| Lyon Joseph Douglas See Remarks | 2025-12-01 | Sale 10b5-1 | −5,000 | $79.53 | $397,632 | 10,277 | D: show line 2 in the form |
| Lyon Joseph Douglas See Remarks | 2025-12-01 | Grant or award 10b5-1 | +178 | $79.78 | $14,201 | 10,455 | D: show line 3 in the form |
| Lyon Joseph Douglas See Remarks | 2025-12-01 | Grant or award 10b5-1 | +178 | 10,633 | D: show line 4 in the form | ||
| Lyon Joseph Douglas See Remarks | 2025-12-02 | Shares withheld for taxes 10b5-1 | −110 | $79.78 | $8,776 | 10,523 | D: show line 5 in the form |
| Open-market sales · 5,000 sh · avg $79.53 · $397,632 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lyon Joseph Douglas See Remarks | 2025-12-01 | Option exercise · Stock option (right to buy) 10b5-1 | −5,000 | 11,571 | D: show line 6 in the form |
Loading xslF345X05/ownership.xml…